²é¿´: 2695  |  »Ø¸´: 4

saliand

гæ (³õÈëÎÄ̳)

[½»Á÷] ŵ»ªÉϺ£Ñз¢ÖÐÐÄÕÐÆ¸

¾ßÌ幤×÷µØµã:
ÉϺ£
н½ð:
ÃæÒé

China Novartis Institutes for BioMedical Research Co., Ltd. (CNIBR) has some job vacancies as below. If you have interested in these jobs, please send your resume with no hesitation cause we'll provide you more chance to promote yourself in your field.

Research Scientist-Liver Disease

For more details, please click our career website: 
http://careers.novartis.com.cn/vacancies.html
To apply this position, please send your resume to sarah.qi@novartis.com 
When you send your resume to sarah.qi@novartis.com, please notice you know this position information via Сľ³æBBS

ŵ»ª£¨Öйú£©ÉúÎïҽѧÑо¿ÓÐÏÞ¹«Ë¾ÊÇŵ»ªÈ«ÇòÑз¢×éÖ¯¨D¨Dŵ»ªÉúÎïҽѧÑо¿Ëù£¨NIBR£©µÄµÚ°Ë¸öÑо¿»ùµØ¡£ÎÒÃÇλÓÚÖйúÉϺ£ÊÐÕŽ­¸ß¿Æ¼¼Ô°Çø£¬½«³ÉΪŵ»ªÔÚÑÇÖÞµÄÖ÷ÒªÑо¿ÖÐÐÄ£¬ÒÔ¼°³ýÔÚÅ·ÃÀµÄÑо¿ÖÐÐÄÍâµÄ×îÖ÷ÒªµÄÑо¿ÖÐÐÄ¡£ÎÒÃǵÄÑо¿ºÍ̽Ë÷¿ª·¢»î¶¯µÄÖØµãÊÇ·¢ÏÖ²¢¿ª·¢´´ÐÂÁÆ·¨£¬ÓÃÓÚÖÎÁÆÔÚÑÇÖÞԶδ´ïµ½Ò½Ò©ÐèÇóµÄ¼²²¡¡£ÎÒÃÇÓë´Ó²»Í¬Ö®´¦ÔÚÓÚ½«×¨×¢ÏÖ´úÒ©ÎïµÄ·¢ÏֺͿª·¢·½·¨µÄÑо¿¡£×î³õ½×¶Î£¬Ñз¢¹¤×÷½«×¨×¢ÔÚÒýÆðÖйúµØ·½ÐÔ°©Ö¢µÄ¸ÐȾԭÒò¡£ÎÒÃÇ»¹½«¿ªÕ¹ÁÙ´²ÊÔÑ飬½øÐа²È«ÐÔÑо¿£¬ÉúÎï±êÖ¾ÎïºÍ¼ì²â·ÖÎö£¬±í´ïÆ×¡¢ÉúÎï·ÖÎöÒÔ¼°×ª»¯Ò½Ñ§µÄÑо¿¡£

Ëæ×Ź«Ë¾ÒµÎñµÄѸËÙÀ©Õ¹£¬ÎÒÃÇÈȳÀ»¶Ó­ÄúµÄ¼ÓÈ롣ͬʱÎÒÃǽ«Ìṩ¾ßÓоºÕùÁ¦µÄн³ê¸£Àû´ýÓöÒÔ¼°Á¼ºÃµÄÅàѵ·¢Õ¹»ú»á¡£

NIBR Shanghai
NIBR Shanghai is an integrated research center that is part of the Novartis global research and development network. The establishment of this strategic site is a commitment by Novartis to conduct cutting-edge pharmaceutical research in China. Research activities at NIBR Shanghai focus on addressing urgent medical needs in China, particularly infectious causes of cancer endemic to the region. The center also established programs in epigenetics, biomarker development, drug metabolism and preclinical safety to support NIBR local and global R&D projects.Research at NIBR Shanghai is currently focused on discovering new therapies for infectious causes of cancer, such as liver cancer caused by HBV or HCV hepatitis. As the diseases are highly prevalent in the region, some one-third of the 400 million people infected with the hepatitis B virus are in China, with estimates that 300,000 people die from liver cancer in the mainland each year.
A Growing and Dynamic Organization
China Novartis Institutes for BioMedical Research Co., Ltd. (CNIBR), the legal entity for NIBR Research Center in Shanghai was launched in November 2006 and the start-up Research facilities opened in April 2007. Today, NIBR Shanghai has grown to an organization of about 260 associates including nearly 200 scientists. The research teams are comprised of both returnee scientists from abroad (about 20% of total scientists), and graduates from top tier universities, medical centers, and research institutes in China.
Currently the center operates in an office building and two lab facilities in the Zhangjiang Hi-Tech Park. In the same area, the new Novartis Shanghai Campus is under design and construction. The first phase of the project will be completed by the end of 2014.
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

saliand

гæ (³õÈëÎÄ̳)

Research Scientist-Liver Disease

Job Description       
China Novartis Institutes for Biomedical Research Co. Ltd (CNIBR) is currently seeking to fill a research scientist position in Biology Department. Self-motivated scientist with strong interest in drug discovery studies in liver diseases, esp in liver fibrosis/cirrhosis is welcome. The candidate will apply cell biology, molecular biology and biochemistry expertise on drug target validation, assay development, novel target identification as well as mechanistic studies. The candidate is expected to have the ability to handle multiple projects simultaneously and works in a fast-paced environment. Oral and written reports in English are also required regularly.

Minimum requirements       
Candidates should hold an M.S./Ph.D. in Cell Biology, Molecular Biology, Developmental Biology or related field and have at least two years of relevant experience. Strong background and hands-on experience in liver diseases is preferred. The successful candidate is expected to have strong work ethic, excellent oral and written communication in English, and ability to function in an interdisciplinary team setting are essential.
2Â¥2013-10-10 17:14:14
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

¿Õ¹ÈÓÄÜø

гæ (³õÈëÎÄ̳)

ÄúºÃ£¡ÎÒÊÇ»ªÖпƼ¼´óѧͬ¼ÃҽѧԺÃâÒßѧӦ½ì²©Ê¿Ñо¿Éú£¬ÎÒ¶ÔÕâ¸öְλ·Ç³£¸ÐÐËȤ£¬²»ÖªµÀÊÇ·ñÓÐE-mialµØÖ·¿ÉÒÔ·¢ËÍϼòÀú£¬·Ç³£ÆÚ´ýÄúµÄ»Ø¸´£¡
3Â¥2013-10-10 22:21:13
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lzmhust

ľ³æ (СÓÐÃûÆø)

ÄúºÃ£¬ÎÒÊÇÖпÆÔº2014Ó¦½ì±ÏÒµÉú£¬¿ÎÌâ·½ÏòÊǵ°°×ÖÊøѧ£¬ÓкܼáʵµÄ·Ö×ÓÉú»¯±³¾°£¬²»Öª¿ÉÒÔÉêÇëNIBR µÄ scientific associate¸Úλô£¬¼òÀúÒÑ·¢ËÍÖÁÄúµÄÓÊÏä¡£
³¤Â·ÂþÂþ~~~
4Â¥2013-10-12 10:07:03
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lzmhust

ľ³æ (СÓÐÃûÆø)

ÒýÓûØÌû:
3Â¥: Originally posted by ¿Õ¹ÈÓÄÜø at 2013-10-10 22:21:13
ÄúºÃ£¡ÎÒÊÇ»ªÖпƼ¼´óѧͬ¼ÃҽѧԺÃâÒßѧӦ½ì²©Ê¿Ñо¿Éú£¬ÎÒ¶ÔÕâ¸öְλ·Ç³£¸ÐÐËȤ£¬²»ÖªµÀÊÇ·ñÓÐE-mialµØÖ·¿ÉÒÔ·¢ËÍϼòÀú£¬·Ç³£ÆÚ´ýÄúµÄ»Ø¸´£¡

sarah.qi@novartis.com  Õâ¸öÊÇÌû×ÓÀïÃæµÄÓʼþ·¢Ë͵ØÖ·£¬×£Ñ§³¤ÉêÇë˳ÀûÀ²£¡
³¤Â·ÂþÂþ~~~
5Â¥2013-10-12 10:17:15
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ saliand µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +6 Ϊѧ666 2026-03-16 6/300 2026-03-17 20:15 by peike
[¿¼ÑÐ] 070300»¯Ñ§319Çóµ÷¼Á +4 ½õÀð0909 2026-03-17 4/200 2026-03-17 18:21 by ÖØ¿ÆÐ¡°ÔÍõ
[¿¼ÑÐ] ²ÄÁϹ¤³Ìר˶µ÷¼Á +5 204818@lcx 2026-03-17 5/250 2026-03-17 17:27 by Little-xue
[¿¼ÑÐ] 274Çóµ÷¼Á0856²ÄÁÏ»¯¹¤ +13 z2839474511 2026-03-11 14/700 2026-03-17 16:51 by share_joy
[¿¼ÑÐ] 26¿¼ÑÐÇóµ÷¼Á +6 ؼºêSir 2026-03-13 6/300 2026-03-17 16:13 by ×íÔÚ·çÀï
[¿¼ÑÐ] ÓÐûÓеÀÌú/ÍÁľµÄÏëµ÷¼ÁÄÏÁÖ£¬¸ø×Ô¼ºÕÐʦµÜÖС« +3 TqlXswl 2026-03-16 7/350 2026-03-17 15:23 by TqlXswl
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤×¨Ë¶µ÷¼Á +5 heming3743 2026-03-16 5/250 2026-03-17 14:03 by Ó¸ÒÌ«¼àÍõ¹«¹«
[¿¼ÑÐ] 326Çóµ÷¼Á +4 ŵ±´¶û»¯Ñ§½±êéê 2026-03-15 7/350 2026-03-16 17:11 by ŵ±´¶û»¯Ñ§½±êéê
[¿¼ÑÐ] 0703Ò»Ö¾Ô¸211 285·ÖÇóµ÷¼Á +5 ly3471z 2026-03-13 5/250 2026-03-16 16:16 by ŶŶ123
[¿¼ÑÐ] 327Çóµ÷¼Á +6 ʰ¹âÈÎȾ 2026-03-15 11/550 2026-03-15 22:47 by ʰ¹âÈÎȾ
[¿¼ÑÐ] 265Çóµ÷¼Á +4 Íþ»¯±ý07 2026-03-12 4/200 2026-03-14 17:23 by userper
[¿¼ÑÐ] 330Çóµ÷¼Á +3 ?½´¸øµ÷¼Á¹òÁË 2026-03-13 3/150 2026-03-14 10:13 by JourneyLucky
[¿¼ÑÐ] ÕÐÊÕ0805£¨²ÄÁÏ£©µ÷¼Á +3 18595523086 2026-03-13 3/150 2026-03-14 00:33 by 123%¡¢
[¿¼ÑÐ] 304Çóµ÷¼Á +6 Mochaaaa 2026-03-12 7/350 2026-03-13 22:18 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 0856²ÄÁÏÓ뻯¹¤301Çóµ÷¼Á +5 ÞÈÊø¹â 2026-03-13 5/250 2026-03-13 22:00 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 0703»¯Ñ§Ò»Ö¾Ô¸211 ×Ü·Ö320Çóµ÷¼Á +5 Â꿨°Í¿¨°¡¹þ 2026-03-11 5/250 2026-03-13 21:40 by JourneyLucky
[˶²©¼ÒÔ°] 085600 260·ÖÇóµ÷¼Á +3 Ìì¿Õ»¹ÏÂÓêô 2026-03-13 5/250 2026-03-13 18:46 by Ìì¿Õ»¹ÏÂÓêô
[¿¼ÑÐ] 295Çóµ÷¼Á +3 Сذ×ÐÖ­ 2026-03-12 3/150 2026-03-13 15:17 by vgtyfty
[ÂÛÎÄͶ¸å] Ͷ¸åÎÊÌâ 5+4 Ðǹâ²ÓÀÃxt 2026-03-12 6/300 2026-03-13 14:17 by god_tian
[¿¼ÑÐ] »¯¹¤Ñ§Ë¶306Çóµ÷¼Á +9 42838695 2026-03-12 9/450 2026-03-13 10:16 by houyaoxu
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û